Pyridostigmine
FDA Approved
Contents
Description
Pyridostigmine is an acetylcholinesterase inhibitor that enhances neuromuscular transmission. It is used in the management of oculomotor nerve palsies and other cranial nerve disorders to improve muscle strength and coordination. The medication has been employed in various neurological conditions affecting eye movement and motor control.
Indications & Therapeutic Use
Myasthenia gravis, oculomotor nerve palsy, neuromuscular transmission disorders
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Pyridostigmine — GNH India
73 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Amindan
EU
Distinon 10mg
10mgtablet
Distinon 60mg
60mgtabletIndia
Gravitor SR
180mgtabletIndia
JAMP PYRIDOSTIGMINE BROMIDE
60 MGtabletCANADA
Kalymin
EU
Kalymin 10 N
EU
Kalymin 60 N
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Pyridostigmine
| Generic Name | Pyridostigmine |
| Brands | 1 brand available |
| Active Ingredient | Pyridostigmine bromide |
| Drug Class | Myasthenia gravis |
| Manufacturer | Valeant Pharmaceuticals |
| Dosage Forms | Tablets 60mg; Extended-release tablets 180mg; Syrup 60mg/5mL |
| Medical Code | N07AA02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes